机译:甲巯咪唑软膏治疗甲状腺功能亢进症的疗效和安全性
Department of Endocrine and Metabolic Diseases, Huashan Hospital, Fudan University, Shanghai 200040, China;
Department of Endocrine and Metabolic Diseases, Huashan Hospital, Fudan University, Shanghai 200040, China;
Department of Endocrine and Metabolic Diseases, Huashan Hospital, Fudan University, Shanghai 200040, China;
Department of ICU, Huashan Hospital, Fudan University, Shanghai 200040, China;
Department of Endocrine and Metabolic Diseases, Changzheng Hospital, the Second Military University, Shanghai 200003, China;
Department of Endocrine and Metabolic Diseases, Changzheng Hospital, the Second Military University, Shanghai 200003, China;
Department of Endocrine and Metabolic Diseases, Changzheng Hospital, the Second Military University, Shanghai 200003, China;
Department of Endocrine and Metabolic Diseases, Changzheng Hospital, the Second Military University, Shanghai 200003, China;
Hyperthyroidism; Methimazole; Ointment; Transdermal administration;
机译:甲硫咪唑15 mg +无机碘38 mg /天和甲乙咪唑30 mg /天作为Graves病中重度甲状腺功能亢进患者的初始疗效和不良反应的比较
机译:甲硫咪唑的新型亲脂性制剂对甲亢猫的每日一次透皮治疗的功效和安全性。
机译:甲硫唑新型亲脂性配方对甲亢猫的每日一次经皮治疗的功效和安全性
机译:SPRINT和STAR方案对马来西亚重症患者的疗效和安全性
机译:免疫调节药物来那度胺在淋巴瘤患者中的安全性和有效性:RU051417I-R-ICE(利妥昔单抗-异环磷酰胺-卡铂-依托泊苷)与来那度胺[R2-ICE]的I / II期开放标签研究的进展初次复发/原发性难治性弥漫性大B细胞淋巴瘤(DLBCL)。
机译:甲硝唑经皮治疗猫甲亢的临床疗效和安全性
机译:透皮甲基唑治疗甲状腺功能亢进症猫治疗的疗效和安全性